StreetInsider.com News Articles

Voyager Technologies signs Geisinger as first VISTA life sciences partner

Thu, 16 Jul 2026 09:00:58 -0400

Voyager Technologies (NYSE: VOYG) has signed a memorandum of understanding with Geisinger, a Pennsylvania-based health system, making Geisinger the first major clinical and life sciences partner of Voyager's Institute for Space, Technology and Advancement, known as VISTA.

Under the agreement, the two organizations will jointly pursue up to $1 million in external funding for research programs that use microgravity conditions to advance biomedical and clinical initiatives. The MOU also provides Geisinger with reserved research resources, tenant access, and payload development support through Starlab and other commercial space infrastructure.

Stated research focus areas include space-based drug development, remote patient monitoring and telehealth, cybersecurity

Voyager Secures Geisinger Partnership

Thu, 16 Jul 2026 09:00:00 -0400

Geisinger becomes VISTA’s first major clinical and life sciences partner

DENVER--(BUSINESS WIRE)-- Voyager Technologies (NYSE: VOYG) has secured Geisinger, one of the largest integrated health systems in the United States, as a Voyager Institute for Space, Technology and Advancement (VISTA) partner. The memorandum of understanding (MOU) marks a significant expansion of VISTA’s reach into the life sciences and biopharma sector, establishing a framework for joint research programs that translate the unique conditions of microgravity into breakthrough pathways for human health.

“Signing a health system of Geisinger’s caliber is a defining moment for VISTA,” said John Baum, chief strategy

Voyager Secures Geisinger Partnership

Thu, 16 Jul 2026 09:00:00 -0400

Geisinger becomes VISTA’s first major clinical and life sciences partner

“Signing a health system of Geisinger’s caliber is a defining moment for VISTA,” said John Baum, chief strategy

Voyager Secures Geisinger Partnership

Thu, 16 Jul 2026 09:00:00 -0400

Geisinger becomes VISTA’s first major clinical and life sciences partner

“Signing a health system of Geisinger’s caliber is a defining moment for VISTA,” said John Baum, chief strategy

Voyager Secures Geisinger Partnership

Thu, 16 Jul 2026 09:00:00 -0400

Geisinger becomes VISTA’s first major clinical and life sciences partner

“Signing a health system of Geisinger’s caliber is a defining moment for VISTA,” said John Baum, chief strategy

Voyager Secures Geisinger Partnership

Thu, 16 Jul 2026 09:00:00 -0400

Geisinger becomes VISTA’s first major clinical and life sciences partner

“Signing a health system of Geisinger’s caliber is a defining moment for VISTA,” said John Baum, chief strategy

Voyager Secures Geisinger Partnership

Thu, 16 Jul 2026 09:00:00 -0400

Geisinger becomes VISTA’s first major clinical and life sciences partner

“Signing a health system of Geisinger’s caliber is a defining moment for VISTA,” said John Baum, chief strategy

Voyager Secures Geisinger Partnership

Thu, 16 Jul 2026 09:00:00 -0400

Geisinger becomes VISTA’s first major clinical and life sciences partner

“Signing a health system of Geisinger’s caliber is a defining moment for VISTA,” said John Baum, chief strategy

Voyager Secures Geisinger Partnership

Thu, 16 Jul 2026 09:00:00 -0400

Geisinger becomes VISTA’s first major clinical and life sciences partner

“Signing a health system of Geisinger’s caliber is a defining moment for VISTA,” said John Baum, chief strategy

Form SCHEDULE 13G Voyager Technologies, Filed by: BANK OF NOVA SCOTIA

Wed, 15 Jul 2026 11:30:00 -0400

si-local-file:///var/storage/secattach/20260715/26772781.html

Form SCHEDULE 13G Voyager Technologies, Filed by: BANK OF NOVA SCOTIA

Wed, 15 Jul 2026 11:30:00 -0400

si-local-file:///var/storage/secattach/20260715/26772781.html

Voyager and Penn State to Advance Pennsylvania’s Space Economy

Wed, 15 Jul 2026 09:00:00 -0400